中东和非洲通用注射剂市场预测至 2028 年 - COVID-19 影响和区域分析（按产品类型（大分子注射剂和小分子注射剂）、容器类型（西林瓶、预混剂、预充注射器、安瓿等）、应用（肿瘤学） 、传染病、心脏病学、糖尿病、免疫学等）和给药途径（静脉内、肌内、皮下等）
No. of Pages: 167 | Report Code: BMIRE00024998 | Category: Life Sciences
No. of Pages: 167 | Report Code: BMIRE00024998 | Category: Life Sciences
中东和中东地区的仿制药注射剂市场非洲预计将从2021年的37.1772亿美元增长到2028年的66.1677亿美元；预计 2021 年至 2028 年复合年增长率为 8.6%。
多个国家的品牌注射剂专利可能会在未来到期多年来，为仿制药注射剂制造商提供了大量有利可图的机会。此外，仿制药注射剂市场的制造商正在通过维持充足的供应链以预防漏洞（例如由 COVID-19 爆发引起的漏洞）来为未来做好准备。 Zydus Cadila 正在大幅降低其仿制药 Remdesivir（即 Remdac）的价格。因此，品牌药专利有效性即将到期可能会为仿制药制造商（包括提供仿制药注射剂的公司）提供重要机会。
中东和中东地区非洲仿制药注射剂市场收入及预测至 2028 年（百万美元）
中东和中东;非洲仿制药注射剂市场细分
中东和非洲非洲仿制药注射剂市场分为产品类型、容器类型、应用、给药途径和国家。根据产品类型，市场分为大分子注射剂和小分子注射剂。 2020年，大分子注射剂领域占据了更大的市场份额。就容器类型而言，市场分为西林瓶、预混剂、预充注射器、安瓿等。 2020年，小瓶细分市场占据最大市场份额。根据应用，市场已细分为肿瘤学、传染病、心脏病学、糖尿病、免疫学等。 2020年，肿瘤学领域占据最大的市场份额。根据给药途径，市场分为静脉注射、肌肉注射、皮下注射等。 2020年，静脉注射细分市场占据最大的市场份额。基于国家、中东和地区非洲仿制药注射剂市场分为沙特阿拉伯、南非、阿联酋以及中东和非洲其他地区。非洲。沙特阿拉伯在 2020 年贡献了相当大的份额。
阿斯利康；百特国际公司；比奥康；费森尤斯公司两合公司；葛兰素史克公司； Hikma 制药公司；强生服务公司；羽扇豆；默克公司有限公司；辉瑞公司；和 Viatris Inc 是中东地区的领先公司之一。非洲仿制药注射剂市场。
Strategic insights for Middle East and Africa Generic Injectables involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 3,717.72 Million |
| Market Size by 2028 | US$ 6,616.77 Million |
| Global CAGR (2021 - 2028) | 8.6% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 产品类型
|
| Regions and Countries Covered | 中东和非洲
|
| Market leaders and key company profiles |
The regional scope of Middle East and Africa Generic Injectables refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Middle East and Africa Generic Injectables Market is valued at US$ 3,717.72 Million in 2021, it is projected to reach US$ 6,616.77 Million by 2028.
As per our report Middle East and Africa Generic Injectables Market, the market size is valued at US$ 3,717.72 Million in 2021, projecting it to reach US$ 6,616.77 Million by 2028. This translates to a CAGR of approximately 8.6% during the forecast period.
The Middle East and Africa Generic Injectables Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Generic Injectables Market report:
The Middle East and Africa Generic Injectables Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Generic Injectables Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Generic Injectables Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East and Africa Generic Injectables Market
